EKF Diagnostics Holdings PLC
LSE:EKF
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
23.6
33.45
|
Price Target |
|
We'll email you a reminder when the closing price reaches GBX.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one EKF stock under the Base Case scenario is 31.9 GBX. Compared to the current market price of 25.7 GBX, EKF Diagnostics Holdings PLC is Undervalued by 19%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
EKF Diagnostics Holdings PLC
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for EKF cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
EKF Diagnostics Holdings PLC
Balance Sheet Decomposition
EKF Diagnostics Holdings PLC
Current Assets | 24.7m |
Cash & Short-Term Investments | 9.8m |
Receivables | 6.7m |
Other Current Assets | 8.2m |
Non-Current Assets | 54.6m |
Long-Term Investments | 226k |
PP&E | 24.9m |
Intangibles | 29.5m |
Other Non-Current Assets | 17k |
Current Liabilities | 5.4m |
Accounts Payable | 4.8m |
Other Current Liabilities | 533k |
Non-Current Liabilities | 5.1m |
Long-Term Debt | 1m |
Other Non-Current Liabilities | 4.1m |
Earnings Waterfall
EKF Diagnostics Holdings PLC
Revenue
|
51m
GBP
|
Cost of Revenue
|
-26.5m
GBP
|
Gross Profit
|
24.5m
GBP
|
Operating Expenses
|
-17.7m
GBP
|
Operating Income
|
6.8m
GBP
|
Other Expenses
|
-2m
GBP
|
Net Income
|
4.8m
GBP
|
Free Cash Flow Analysis
EKF Diagnostics Holdings PLC
GBP | |
Free Cash Flow | GBP |
EKF Profitability Score
Profitability Due Diligence
EKF Diagnostics Holdings PLC's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
Score
EKF Diagnostics Holdings PLC's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
EKF Solvency Score
Solvency Due Diligence
EKF Diagnostics Holdings PLC's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Score
EKF Diagnostics Holdings PLC's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
EKF Price Targets Summary
EKF Diagnostics Holdings PLC
According to Wall Street analysts, the average 1-year price target for EKF is 35.7 GBX with a low forecast of 29.29 GBX and a high forecast of 40.95 GBX.
Dividends
Current shareholder yield for EKF is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
EKF Diagnostics Holdings Plc is a vitro diagnostics company, which designs and manufactures diagnostic equipment for use within point-of-care settings. The company is headquartered in Penarth, South Glamorgan. The company went IPO on 2002-06-05. The firm's point-of-care range includes hemoglobin analyzers, HbA1c analyzers and glucose analyzers for use in the screening, monitoring and diagnosis of patients, as well as rapid tests for pregnancy and common infectious diseases. Its Central Laboratory division includes a range of products for use in both large and small laboratory facilities. Its subsidiary, EKF Life Sciences, provides bulk diagnostic enzyme manufacturing and fermentation services. EKF Life Sciences specializes in producing enzymes, including Salicylate Hydroxylase and Beta-Hydroxybutyrate Dehydrogenase. Its products include Quo-Test A1c, Biosen, Quo-Lab A1c, UltraCrit, DiaSpect, HemataStat II and Creamatocrit Plus. The company operates in Germany, the United States, Russia and the United Kingdom.
Contact
IPO
Employees
Officers
The intrinsic value of one EKF stock under the Base Case scenario is 31.9 GBX.
Compared to the current market price of 25.7 GBX, EKF Diagnostics Holdings PLC is Undervalued by 19%.